Atlas Trials

Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI

Clinical trial NCT06870370 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06870370
Sponsor
Tanta University
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Traumatic Brain Injury (TBI) PatientsIntracranial PressureIntensive Care UnitMortality
Start date
2025-09-20
Primary completion
2025-09-20
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.